ANGIODYNAMICS INC Quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent in USD from Q3 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Summary
Angiodynamics Inc quarterly/annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and growth rate from Q3 2015 to Q3 2024.
  • Angiodynamics Inc Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending August 31, 2024 was -$11.7M, a 126% decline year-over-year.
  • Angiodynamics Inc Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the twelve months ending August 31, 2024 was -$241M, a 1718793% decline year-over-year.
  • Angiodynamics Inc annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2023 was -$184M, a 214% decline from 2022.
  • Angiodynamics Inc annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2022 was -$58.5M, a 106% decline from 2021.
  • Angiodynamics Inc annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2021 was -$28.3M, a 4.77% decline from 2020.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Trailing 12 Months (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Quarterly (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$241M -$11.7M -$56.7M -126% Jun 1, 2024 Aug 31, 2024 10-Q 2024-10-03
Q2 2024 -$184M -$15M +$7.33M +32.8% Mar 1, 2024 May 31, 2024 10-K 2024-07-25
Q1 2024 -$191M -$186M -$173M -1324% Dec 1, 2023 Feb 29, 2024 10-Q 2024-04-09
Q4 2023 -$18.5M -$28.1M -$18.5M -193% Sep 1, 2023 Nov 30, 2023 10-Q 2024-01-08
Q3 2023 -$14K $45M +$58.5M Jun 1, 2023 Aug 31, 2023 10-Q 2024-10-03
Q2 2023 -$58.5M -$22.3M -$13.9M -165% Mar 1, 2023 May 31, 2023 10-K 2024-07-25
Q1 2023 -$44.6M -$13M -$7.05M -118% Dec 1, 2022 Feb 28, 2023 10-Q 2024-04-09
Q4 2022 -$37.6M -$9.58M -$2.05M -27.2% Sep 1, 2022 Nov 30, 2022 10-Q 2024-01-08
Q3 2022 -$35.5M -$13.6M -$7.17M -112% Jun 1, 2022 Aug 31, 2022 10-Q 2023-10-05
Q2 2022 -$28.3M -$8.44M +$9.83M +53.8% Mar 1, 2022 May 31, 2022 10-K 2024-07-25
Q1 2022 -$38.2M -$5.99M -$2.46M -69.7% Dec 1, 2021 Feb 28, 2022 10-Q 2023-03-31
Q4 2021 -$35.7M -$7.53M -$4.44M -144% Sep 1, 2021 Nov 30, 2021 10-Q 2023-01-06
Q3 2021 -$31.3M -$6.38M -$4.21M -194% Jun 1, 2021 Aug 31, 2021 10-Q 2022-10-11
Q2 2021 -$27.1M -$18.3M +$139M +88.4% Mar 1, 2021 May 31, 2021 10-K 2023-08-03
Q1 2021 -$166M -$3.53M +$2.17M +38% Dec 1, 2020 Feb 28, 2021 10-Q 2022-04-07
Q4 2020 -$168M -$3.09M -$583K -23.3% Sep 1, 2020 Nov 30, 2020 10-Q 2022-01-07
Q3 2020 -$168M -$2.17M -$747K -52.4% Jun 1, 2020 Aug 31, 2020 10-Q 2021-09-30
Q2 2020 -$167M -$157M -$216M -368% Mar 1, 2020 May 31, 2020 10-K 2022-07-22
Q1 2020 $49M -$5.7M -$6.67M -688% Dec 1, 2019 Feb 29, 2020 10-Q 2021-03-31
Q4 2019 $55.6M -$2.51M -$4.44M -230% Sep 1, 2019 Nov 30, 2019 10-Q 2021-01-08
Q3 2019 $60.1M -$1.43M -$865K -154% Jun 1, 2019 Aug 31, 2019 10-Q 2020-10-07
Q2 2019 $60.9M $58.6M +$56.8M +3179% Mar 1, 2019 May 31, 2019 10-K 2021-07-27
Q1 2019 $4.13M $969K -$13.3M -93.2% Dec 1, 2018 Feb 28, 2019 10-Q 2020-04-08
Q4 2018 $17.4M $1.93M +$1.49M +336% Sep 1, 2018 Nov 30, 2018 10-Q 2020-01-08
Q3 2018 $15.9M -$561K -$809K -326% Jun 1, 2018 Aug 31, 2018 10-Q 2019-10-04
Q2 2018 $16.7M $1.79M Mar 1, 2018 May 31, 2018 10-K 2020-08-10
Q1 2018 $14.2M +$11.4M +400% Dec 1, 2017 Feb 28, 2018 10-Q 2019-04-02
Q4 2017 $444K -$12.7M -96.6% Sep 1, 2017 Nov 30, 2017 10-Q 2019-01-07
Q3 2017 $248K -$754K -75.3% Jun 1, 2017 Aug 31, 2017 10-Q 2018-10-01
Q1 2017 $2.84M +$2.12M +291% Dec 1, 2016 Feb 28, 2017 10-Q 2018-04-05
Q4 2016 $13.2M +$13.8M Sep 1, 2016 Nov 30, 2016 10-Q 2018-01-05
Q3 2016 $1M +$1.82M Jun 1, 2016 Aug 31, 2016 10-Q 2017-09-29
Q1 2016 $728K Dec 1, 2015 Feb 29, 2016 10-Q 2017-04-03
Q4 2015 -$642K Sep 1, 2015 Nov 30, 2015 10-Q 2017-01-06
Q3 2015 -$822K Jun 1, 2015 Aug 31, 2015 10-Q 2016-10-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.